Argentina's Chamber of Deputies has recently approved legislation allowing for the country’s accession to the PCT. Once accession has occurred, PCT membership will simplify international patent filing strategies and extend decision-making timelines for applicants.

Argentina has repealed various biotech patent restrictions, restoring a more permissive, internationally aligned framework. This enables broader claims, reduces disclosure burdens, and, combined with fast-track examination, makes obtaining strong biotech patents easier and quicker.

Argentina has taken a significant step towards aligning its patent system with international standards, with the repeal of long-standing restrictions on pharmaceutical patentability. For applicants, this represents a meaningful shift, reopening categories of protection that have effectively been closed for over a decade.